Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Female Luer-lock to female Luer-lock connector, with Qimo Female on both ends of the connector.
The main indication of this device is the transfer of drugs from syringe to syringe.
Qimo Female is a multi-purpose, closed, needle-free, I.V. connection device. See the corresponding technical file code 7210.02.
Priming volume: 0.27 ml